| Babatunji O Omotoso, MD | |
|
300 2nd Ave, Long Branch, NJ 07740-6303 | |
| (732) 222-5200 | |
| Not Available |
| Full Name | Babatunji O Omotoso |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 40 Years |
| Location | 300 2nd Ave, Long Branch, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336146851 | NPI | - | NPPES |
| 7865708 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MA 65839 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allied Digestive Health Llc | 5991027583 | 216 |
News Archive
A Medicare panel meant to help lawmakers make tough choices about cutting costs in the program has drawn bipartisan ire, Bloomberg BusinessWeek reports.
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
› Verified 2 days ago
| Entity Name | North American Partners In Anesthesia Of New Jersey Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548433048 PECOS PAC ID: 5890867410 Enrollment ID: O20080626000318 |
News Archive
A Medicare panel meant to help lawmakers make tough choices about cutting costs in the program has drawn bipartisan ire, Bloomberg BusinessWeek reports.
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
› Verified 2 days ago
| Entity Name | Coastal Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801189337 PECOS PAC ID: 5092983064 Enrollment ID: O20110718000411 |
News Archive
A Medicare panel meant to help lawmakers make tough choices about cutting costs in the program has drawn bipartisan ire, Bloomberg BusinessWeek reports.
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
› Verified 2 days ago
| Entity Name | Allied Digestive Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265831259 PECOS PAC ID: 5991027583 Enrollment ID: O20141210001569 |
News Archive
A Medicare panel meant to help lawmakers make tough choices about cutting costs in the program has drawn bipartisan ire, Bloomberg BusinessWeek reports.
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Babatunji O Omotoso, MD Po Box 1637, Elizabeth, NJ 07207-1637 Ph: (201) 804-2800 | Babatunji O Omotoso, MD 300 2nd Ave, Long Branch, NJ 07740-6303 Ph: (732) 222-5200 |
News Archive
A Medicare panel meant to help lawmakers make tough choices about cutting costs in the program has drawn bipartisan ire, Bloomberg BusinessWeek reports.
MultiCell Technologies, Inc. is pleased to announce the signing of a new sponsored research agreement with Anand Ghanekar, M.D., Ph.D, of the University Health Network's Toronto General Hospital expanding the scope of the research project to evaluate MCT-485 in animal models for the treatment of primary liver cancer.
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).
As the implantation of cardioverter-defibrillator devices to prevent sudden cardiac death becomes increasingly popular, patients are likely to get the best results when they are treated by physicians who perform the procedures frequently, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.
› Verified 2 days ago
Dr. Matthew Phillip Zlotnick, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 Second Ave, Long Branch, NJ 07740 Phone: 732-923-6980 | |
Dr. David C Kramer, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Michael H Flashburg, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Dr. Mark Jack Der Mesropian, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Matthew Klein, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 300 Second Avenue, Monmouth Medical Center, Long Branch, NJ 07740 Phone: 732-222-5200 | |
Debra J Molbegott, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 279 3rd Ave, Long Branch, NJ 07740 Phone: 732-222-7373 Fax: 732-229-1556 | |
Dr. Joshua Lyn Spruell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Ste 251, Long Branch, NJ 07740 Phone: 732-923-6769 |